Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Three series of orexin antagonists patented by GSK researchers

June 25, 2004

Orally active small molecule erythropoietic agent for the treatment of anemia

June 25, 2004

Studies support further investigation of T-131 in type 2 diabetes

June 23, 2004

Novel glycogen phosphorylase inhibitors under study at Pfizer

June 23, 2004

Therapeutic benefits of rimonabant in obese subjects and a preclinical model of obesity

June 23, 2004

Quinazoline-based calcilytic agents newly developed at NPS

June 22, 2004

Boehringer Ingelheim presents novel xanthine-based DPP-IV inhibitors

June 22, 2004

Prosidion to acquire DPP-IV platform from Probiodrug

June 22, 2004

ATL-962 reported to reduce body weight of obese patients

June 22, 2004

Weight loss and appetite reduction found with Axokine in overweight/obese subjects

June 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...